Title:
養子細胞免疫療法の有効性を増強させるための組成物および方法
Document Type and Number:
Japanese Patent JP7005346
Kind Code:
B2
Abstract:
The present disclosure provides compositions and methods for boosting, augmenting or enhancing the efficacy of the adoptive cellular immunotherapy by using modified T cells expressing an antigen binding protein in conjunction with modified cells (such as hematopoietic progenitor cells, modified human immune system cells or a combination thereof) expressing the antigen specifically bound by the antigen binding protein of the modified T cells.
Inventors:
Burger, Susanna Carolina
Liddell, Stanley Earl.
Liddell, Stanley Earl.
Application Number:
JP2017522502A
Publication Date:
February 04, 2022
Filing Date:
October 27, 2015
Export Citation:
Assignee:
Fred Hutchinson Cancer Research Center
International Classes:
A61K35/17; A61K38/20; A61K39/395; A61K48/00; A61P29/00; A61P31/04; A61P31/12; A61P35/00; A61P35/02; A61P37/02; A61P37/04; A61P43/00
Domestic Patent References:
| JP2013116891A | ||||
| JP2014510108A |
Other References:
Cancer Research,2004年,Vol.64,pp.6783-6790
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto